Antidote [EPC]

Antidote [EPC] was reported 63406 times

Drugs of the Antidote [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CONGENITAL HIATUS HERNIA 119 0.5219
1 BODY TINEA 45 0.0804
2 MALIGNANT MELANOMA IN SITU 88 0.0710
3 INHIBITORY DRUG INTERACTION 55 0.0347
4 BREATH SOUNDS ABNORMAL 157 0.0318
5 BENIGN PROSTATIC HYPERPLASIA 155 0.0300
6 MUSCLE CRAMP 52 0.0293
7 BRONCHIECTASIS 181 0.0268
8 EMPYEMA 47 0.0236
9 NEPHROGENIC ANAEMIA 108 0.0233
10 HAEMORRHAGIC ANAEMIA 102 0.0232
11 INFECTION SUSCEPTIBILITY INCREASED 49 0.0224
12 DEVICE RELATED SEPSIS 41 0.0203
13 HYPERPARATHYROIDISM SECONDARY 50 0.0199
14 VENOOCCLUSIVE DISEASE 47 0.0188
15 BLOOD TESTOSTERONE DECREASED 118 0.0172
16 MICTURITION URGENCY 183 0.0160
17 REBOUND ACID HYPERSECRETION 48 0.0159
18 WOUND COMPLICATION 54 0.0157
19 INJECTION SITE PAPULE 69 0.0151
20 LOWER GASTROINTESTINAL HAEMORRHAGE 105 0.0142
21 OBSTRUCTIVE AIRWAYS DISORDER 155 0.0139
22 FULL BLOOD COUNT ABNORMAL 147 0.0139
23 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 74 0.0136
24 ABDOMINAL ABSCESS 60 0.0136
25 KLEBSIELLA INFECTION 67 0.0132
26 PRE-EXISTING CONDITION IMPROVED 82 0.0131
27 STAPHYLOCOCCAL BACTERAEMIA 57 0.0131
28 SPINAL COLUMN STENOSIS 60 0.0127
29 GLUCOSE TOLERANCE IMPAIRED 75 0.0127
30 SKIN ABRASION 59 0.0125
31 ANAPHYLACTOID REACTION 51 0.0124
32 COAGULOPATHY 204 0.0122
33 BODY HEIGHT DECREASED 130 0.0121
34 HYPERCHOLESTEROLAEMIA 117 0.0121
35 TOXIC EPIDERMAL NECROLYSIS 181 0.0119
36 IDIOPATHIC PULMONARY FIBROSIS 46 0.0116
37 VITAMIN D DECREASED 99 0.0116
38 GOITRE 47 0.0115
39 STAPHYLOCOCCAL SEPSIS 55 0.0111
40 ENTEROCOCCAL INFECTION 53 0.0110
41 FAECAL INCONTINENCE 52 0.0108
42 DIFFICULTY IN WALKING 37 0.0107
43 ENDOMETRIOSIS 51 0.0107
44 TENDON PAIN 80 0.0106
45 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 537 0.0103
46 ATELECTASIS 97 0.0100
47 DYSPNOEA EXERTIONAL 370 0.0098
48 SINUS HEADACHE 58 0.0098
49 MENISCUS INJURY 60 0.0097
50 WALKING AID USER 64 0.0097
51 VASCULAR DEVICE INFECTION 44 0.0097
52 SPINAL OSTEOARTHRITIS 85 0.0097
53 INITIAL INSOMNIA 99 0.0096
54 CHROMATURIA 216 0.0096
55 HYPERLIPIDAEMIA 114 0.0095
56 THERAPY CESSATION 488 0.0095
57 JOINT INJURY 203 0.0095
58 BRAIN OEDEMA 119 0.0094
59 PRODUCTIVE COUGH 446 0.0093
60 CLOSTRIDIUM DIFFICILE COLITIS 99 0.0093
61 PRODUCT SUBSTITUTION ISSUE 536 0.0093
62 ACUTE RESPIRATORY FAILURE 179 0.0093
63 PHARYNGOLARYNGEAL PAIN 49 0.0092
64 INCREASED UPPER AIRWAY SECRETION 47 0.0091
65 UPPER-AIRWAY COUGH SYNDROME 75 0.0091
66 INTENTIONAL DEVICE MISUSE 40 0.0091
67 AMMONIA INCREASED 46 0.0090
68 RALES 52 0.0089
69 TRANSIENT ISCHAEMIC ATTACK 301 0.0089
70 HUMERUS FRACTURE 43 0.0089
71 ACIDOSIS 68 0.0089
72 BLOOD CALCIUM INCREASED 78 0.0089
73 LACERATION 83 0.0088
74 PERONEAL NERVE PALSY 50 0.0088
75 PELVIC PAIN 159 0.0087
76 MUSCLE FATIGUE 37 0.0087
77 CLOSTRIDIUM DIFFICILE INFECTION 190 0.0087
78 BLOOD MAGNESIUM DECREASED 75 0.0087
79 PULMONARY FUNCTION TEST DECREASED 38 0.0087
80 UPPER GASTROINTESTINAL HAEMORRHAGE 145 0.0086
81 INCREASED TENDENCY TO BRUISE 79 0.0086
82 POOR QUALITY SLEEP 184 0.0085
83 ATRIAL FLUTTER 68 0.0085
84 STOMACH DISCOMFORT 44 0.0085
85 BUNDLE BRANCH BLOCK RIGHT 39 0.0085
86 MIDDLE INSOMNIA 158 0.0085
87 SMALL INTESTINAL OBSTRUCTION 104 0.0084
88 SINUS CONGESTION 114 0.0084
89 LOCAL SWELLING 147 0.0084
90 HYPOVOLAEMIA 49 0.0084
91 HEPATIC ENCEPHALOPATHY 78 0.0084
92 EXERCISE TOLERANCE DECREASED 48 0.0083
93 EXOSTOSIS 76 0.0083
94 VITAMIN D DEFICIENCY 80 0.0082
95 FULL BLOOD COUNT DECREASED 165 0.0082
96 END STAGE RENAL DISEASE 149 0.0082
97 TENDERNESS 85 0.0081
98 ORTHOSTATIC HYPOTENSION 142 0.0081
99 DYSMENORRHOEA 108 0.0081
100 HAEMATOCRIT DECREASED 161 0.0081
101 STEVENS-JOHNSON SYNDROME 179 0.0080
102 MENORRHAGIA 158 0.0080
103 LEUKOCYTOSIS 145 0.0080
104 BALANCE DISORDER 692 0.0080
105 NEUTROPENIC SEPSIS 57 0.0080
106 ACUTE HEPATIC FAILURE 109 0.0080
107 DECREASED INTEREST 47 0.0080
108 TRICUSPID VALVE INCOMPETENCE 63 0.0079
109 PHOTOPSIA 50 0.0079
110 CARDIAC FLUTTER 51 0.0079
111 PNEUMONIA ASPIRATION 197 0.0079
112 HYPOXIA 277 0.0079
113 GASTROOESOPHAGEAL REFLUX DISEASE 632 0.0078
114 BLOOD POTASSIUM DECREASED 236 0.0078
115 MULTIPLE ALLERGIES 61 0.0078
116 FLUID OVERLOAD 113 0.0078
117 TENDONITIS 120 0.0077
118 BACTERAEMIA 91 0.0077
119 INJECTION SITE NODULE 84 0.0076
120 THERAPY CHANGE 75 0.0076
121 PANIC REACTION 55 0.0076
122 CHEILITIS 41 0.0076
123 ROTATOR CUFF SYNDROME 97 0.0075
124 BLOOD IRON DECREASED 89 0.0075
125 MUSCLE ATROPHY 95 0.0075
126 ABNORMAL LOSS OF WEIGHT 51 0.0075
127 SOMNAMBULISM 49 0.0075
128 COMPRESSION FRACTURE 40 0.0075
129 CELLULITIS 376 0.0075
130 ENERGY INCREASED 44 0.0074
131 ABDOMINAL TENDERNESS 37 0.0074
132 UTERINE LEIOMYOMA 54 0.0074
133 INTERVERTEBRAL DISC DEGENERATION 68 0.0073
134 PURPURA 65 0.0073
135 NOCTURIA 89 0.0073
136 ACTIVITIES OF DAILY LIVING IMPAIRED 145 0.0073
137 CHOLECYSTITIS CHRONIC 49 0.0073
138 AGEUSIA 182 0.0073
139 MUSCULOSKELETAL PAIN 382 0.0073
140 MUSCLE STRAIN 63 0.0073
141 INTERNATIONAL NORMALISED RATIO INCREASED 207 0.0073
142 SPINAL COMPRESSION FRACTURE 60 0.0072
143 HYPOMAGNESAEMIA 101 0.0072
144 BRUXISM 39 0.0072
145 FLATULENCE 410 0.0072
146 IMPAIRED DRIVING ABILITY 82 0.0072
147 BLOOD LACTIC ACID INCREASED 38 0.0072
148 URINE OUTPUT DECREASED 63 0.0072
149 RESTLESS LEGS SYNDROME 130 0.0071
150 ANORECTAL DISCOMFORT 38 0.0071
151 SLEEP APNOEA SYNDROME 136 0.0071
152 MENSTRUAL DISORDER 59 0.0071
153 PRODUCT FORMULATION ISSUE 47 0.0071
154 CORONARY ARTERY DISEASE 215 0.0071
155 HOSPICE CARE 70 0.0071
156 MUSCLE SPASTICITY 87 0.0071
157 HYPOPHAGIA 181 0.0071
158 HYPERKERATOSIS 39 0.0071
159 IMPAIRED WORK ABILITY 151 0.0071
160 BLOOD ALBUMIN DECREASED 56 0.0071
161 OSTEOPENIA 107 0.0070
162 DRY MOUTH 572 0.0070
163 SKIN WARM 41 0.0070
164 TENDON RUPTURE 87 0.0070
165 UROSEPSIS 65 0.0070
166 BREAST TENDERNESS 53 0.0070
167 WHEEZING 416 0.0070
168 SCAB 80 0.0070
169 SINUSITIS 716 0.0070
170 TEMPERATURE INTOLERANCE 72 0.0070
171 METABOLIC ACIDOSIS 223 0.0070
172 RASH PAPULAR 156 0.0070
173 PRURITUS GENERALISED 150 0.0069
174 VENTRICULAR EXTRASYSTOLES 72 0.0069
175 PERIPHERAL COLDNESS 95 0.0069
176 VAGINAL DISCHARGE 70 0.0069
177 HAND FRACTURE 49 0.0069
178 SCREAMING 44 0.0069
179 HYPOAESTHESIA ORAL 104 0.0069
180 ELECTROCARDIOGRAM ABNORMAL 54 0.0069
181 PROCTALGIA 44 0.0068
182 FLANK PAIN 64 0.0068
183 BLOOD UREA INCREASED 114 0.0068
184 SQUAMOUS CELL CARCINOMA OF SKIN 41 0.0068
185 PAROSMIA 51 0.0068
186 GROIN PAIN 59 0.0067
187 DEFAECATION URGENCY 47 0.0067
188 HICCUPS 55 0.0067
189 HYPONATRAEMIA 376 0.0067
190 FEELING JITTERY 127 0.0067
191 NERVE INJURY 74 0.0066
192 POOR QUALITY DRUG ADMINISTERED 43 0.0066
193 URINE ODOUR ABNORMAL 39 0.0066
194 GASTROINTESTINAL HAEMORRHAGE 552 0.0066
195 LIVER FUNCTION TEST ABNORMAL 192 0.0066
196 DIZZINESS POSTURAL 64 0.0066
197 PULMONARY CONGESTION 87 0.0066
198 BLOOD COUNT ABNORMAL 100 0.0066
199 HYPERAESTHESIA 54 0.0066
200 LUNG INFILTRATION 58 0.0066
201 PANIC ATTACK 239 0.0066
202 MUSCLE TIGHTNESS 106 0.0065
203 RENAL FAILURE ACUTE 277 0.0065
204 BRONCHITIS 483 0.0065
205 PROTHROMBIN TIME PROLONGED 39 0.0065
206 VAGINAL HAEMORRHAGE 283 0.0065
207 SINUS DISORDER 129 0.0065
208 DRY THROAT 66 0.0065
209 DERMATITIS BULLOUS 47 0.0065
210 ARTHROPOD BITE 48 0.0065
211 SUPRAVENTRICULAR TACHYCARDIA 62 0.0065
212 LIGAMENT SPRAIN 64 0.0065
213 TINNITUS 297 0.0065
214 METRORRHAGIA 110 0.0064
215 BLOOD ALKALINE PHOSPHATASE INCREASED 160 0.0064
216 PULMONARY HYPERTENSION 134 0.0064
217 RENAL TUBULAR NECROSIS 63 0.0064
218 RIGHT VENTRICULAR FAILURE 45 0.0064
219 POST-TRAUMATIC STRESS DISORDER 43 0.0064
220 FLUSHING 652 0.0064
221 INJECTION SITE HAEMORRHAGE 512 0.0064
222 HIATUS HERNIA 83 0.0064
223 MUSCULAR WEAKNESS 728 0.0064
224 CONTUSION 616 0.0064
225 HYPERCALCAEMIA 79 0.0064
226 IRON DEFICIENCY ANAEMIA 59 0.0064
227 RESPIRATION ABNORMAL 44 0.0064
228 CHRONIC KIDNEY DISEASE 485 0.0064
229 PARAESTHESIA ORAL 92 0.0064
230 MENSTRUATION DELAYED 69 0.0064
231 SEASONAL ALLERGY 90 0.0064
232 CORONARY ARTERY OCCLUSION 87 0.0063
233 UPPER RESPIRATORY TRACT INFECTION 293 0.0063
234 RECTAL HAEMORRHAGE 272 0.0063
235 GALLBLADDER DISORDER 113 0.0063
236 OSTEOPOROSIS 260 0.0063
237 OEDEMA PERIPHERAL 770 0.0063
238 HOT FLUSH 476 0.0063
239 TROPONIN INCREASED 48 0.0063
240 LIP SWELLING 210 0.0063
241 MOOD SWINGS 201 0.0063
242 FREQUENT BOWEL MOVEMENTS 170 0.0063
243 JOINT STIFFNESS 165 0.0063
244 CYST 78 0.0063
245 BREAST PAIN 67 0.0063
246 URINARY INCONTINENCE 186 0.0063
247 BOWEL MOVEMENT IRREGULARITY 48 0.0063
248 DEEP VEIN THROMBOSIS 407 0.0063
249 GASTROENTERITIS VIRAL 113 0.0063
250 HYPERSOMNIA 179 0.0062
251 NIGHT SWEATS 201 0.0062
252 RESPIRATORY TRACT CONGESTION 99 0.0062
253 MENTAL STATUS CHANGES 173 0.0062
254 ABNORMAL FAECES 51 0.0062
255 CANDIDA INFECTION 105 0.0062
256 POLLAKIURIA 259 0.0062
257 LETHARGY 357 0.0062
258 RHINITIS 50 0.0062
259 INFUSION SITE SWELLING 39 0.0062
260 PLEURAL EFFUSION 377 0.0062
261 TOOTHACHE 112 0.0062
262 MUSCLE SPASMS 1135 0.0062
263 RASH PRURITIC 335 0.0062
264 HYPOKALAEMIA 285 0.0062
265 THERAPEUTIC RESPONSE UNEXPECTED 277 0.0062
266 HYPOALBUMINAEMIA 48 0.0062
267 WRIST FRACTURE 74 0.0062
268 INJECTION SITE BRUISING 492 0.0062
269 INSOMNIA 1639 0.0061
270 DECUBITUS ULCER 50 0.0061
271 TENDON DISORDER 40 0.0061
272 ACUTE KIDNEY INJURY 938 0.0061
273 ATRIAL FIBRILLATION 596 0.0061
274 RENAL FAILURE CHRONIC 47 0.0061
275 ONYCHOCLASIS 42 0.0061
276 APHONIA 85 0.0061
277 MALNUTRITION 68 0.0061
278 CARPAL TUNNEL SYNDROME 85 0.0061
279 DIVERTICULITIS 168 0.0061
280 BLOOD URINE PRESENT 115 0.0061
281 GAIT DISTURBANCE 1159 0.0060
282 ASPARTATE AMINOTRANSFERASE INCREASED 321 0.0060
283 FAECES DISCOLOURED 131 0.0060
284 ARTERIOSCLEROSIS CORONARY ARTERY 40 0.0060
285 PARAESTHESIA 949 0.0060
286 RIB FRACTURE 124 0.0060
287 TOOTH DISORDER 134 0.0060
288 FALL 2001 0.0060
289 PULMONARY HAEMORRHAGE 47 0.0060
290 DYSGEUSIA 446 0.0060
291 HERPES SIMPLEX 39 0.0060
292 TOOTH INFECTION 79 0.0060
293 DISTURBANCE IN ATTENTION 323 0.0060
294 MUSCLE TWITCHING 138 0.0060
295 PAIN IN JAW 169 0.0060
296 NASAL CONGESTION 350 0.0059
297 ENTERITIS 38 0.0059
298 ASPIRATION 65 0.0059
299 RHINORRHOEA 383 0.0059
300 RENAL CYST 47 0.0059
301 CYANOSIS 93 0.0059
302 RESPIRATORY TRACT INFECTION 154 0.0059
303 NASAL DRYNESS 37 0.0059
304 SCAR 101 0.0059
305 BLOOD SODIUM DECREASED 111 0.0059
306 NECK PAIN 329 0.0059
307 HAEMOPTYSIS 164 0.0059
308 PNEUMONIA 1901 0.0059
309 DEHYDRATION 783 0.0059
310 RASH GENERALISED 152 0.0059
311 PARANOIA 101 0.0059
312 ABDOMINAL DISTENSION 611 0.0058
313 NERVE COMPRESSION 54 0.0058
314 BLADDER DISORDER 58 0.0058
315 ERUCTATION 113 0.0058
316 HYPOAESTHESIA 874 0.0058
317 HAEMODIALYSIS 49 0.0058
318 RASH MACULAR 204 0.0058
319 CONSTIPATION 1271 0.0058
320 ANOREXIA 75 0.0058
321 BONE DISORDER 106 0.0058
322 SENSATION OF FOREIGN BODY 49 0.0058
323 VIRAL INFECTION 193 0.0058
324 LUNG INFECTION 90 0.0058
325 LYMPHOEDEMA 40 0.0058
326 DYSURIA 212 0.0058
327 HEART RATE IRREGULAR 130 0.0057
328 EMPHYSEMA 58 0.0057
329 EAR DISCOMFORT 59 0.0057
330 SWELLING FACE 374 0.0057
331 ASTHENIA 2158 0.0057
332 PALPITATIONS 672 0.0057
333 LABORATORY TEST ABNORMAL 169 0.0057
334 RESPIRATORY FAILURE 417 0.0057
335 NEURALGIA 139 0.0057
336 HAEMOGLOBIN DECREASED 586 0.0057
337 ABASIA 141 0.0057
338 SKIN INFECTION 64 0.0057
339 STAPHYLOCOCCAL INFECTION 188 0.0057
340 TOOTH ABSCESS 58 0.0057
341 MYALGIA 968 0.0057
342 PHOTOPHOBIA 107 0.0057
343 ORAL HERPES 111 0.0057
344 BACK PAIN 1321 0.0057
345 MUSCULOSKELETAL CHEST PAIN 88 0.0057
346 CHEST DISCOMFORT 582 0.0057
347 HYPOPHOSPHATAEMIA 42 0.0057
348 BACTERIAL INFECTION 106 0.0057
349 ATRIOVENTRICULAR BLOCK COMPLETE 38 0.0057
350 DYSPHONIA 332 0.0057
351 FEELING HOT 348 0.0057
352 NASAL DISCOMFORT 45 0.0057
353 SECRETION DISCHARGE 71 0.0057
354 TACHYPNOEA 77 0.0057
355 BREAST MASS 38 0.0057
356 GINGIVAL PAIN 45 0.0056
357 FEELING DRUNK 42 0.0056
358 AORTIC ANEURYSM 43 0.0056
359 BLOOD THYROID STIMULATING HORMONE INCREASED 52 0.0056
360 TRANSFUSION 59 0.0056
361 CHILLS 660 0.0056
362 LARGE INTESTINE POLYP 39 0.0056
363 DIVERTICULUM 40 0.0056
364 UNEVALUABLE EVENT 425 0.0056
365 MENTAL IMPAIRMENT 136 0.0056
366 BACK INJURY 61 0.0056
367 SKIN DISORDER 187 0.0056
368 BRONCHOSPASM 80 0.0056
369 NAIL DISORDER 49 0.0056
370 PSEUDOMONAS INFECTION 48 0.0056
371 HEPATOMEGALY 55 0.0056
372 RED BLOOD CELL COUNT DECREASED 160 0.0056
373 HALLUCINATION, VISUAL 118 0.0056
374 SLUGGISHNESS 57 0.0056
375 COLD SWEAT 98 0.0056
376 EAR PAIN 108 0.0055
377 BLOOD BILIRUBIN INCREASED 150 0.0055
378 PRESYNCOPE 135 0.0055
379 SENSORY DISTURBANCE 89 0.0055
380 HEAD DISCOMFORT 98 0.0055
381 FEELING ABNORMAL 1326 0.0055
382 TOOTH FRACTURE 61 0.0055
383 DISORIENTATION 219 0.0055
384 CATARACT 329 0.0055
385 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 393 0.0055
386 SQUAMOUS CELL CARCINOMA 52 0.0055
387 ABDOMINAL PAIN 1285 0.0055
388 DEVICE RELATED INFECTION 85 0.0055
389 PELVIC FRACTURE 43 0.0055
390 MUSCULOSKELETAL DISCOMFORT 95 0.0055
391 PULMONARY EMBOLISM 524 0.0055
392 DYSSTASIA 161 0.0055
393 BASAL CELL CARCINOMA 86 0.0055
394 DYSPEPSIA 542 0.0055
395 CRYING 200 0.0055
396 OROPHARYNGEAL PAIN 509 0.0055
397 HEAD INJURY 174 0.0055
398 FATIGUE 4278 0.0055
399 HAIR GROWTH ABNORMAL 38 0.0055
400 INTERVERTEBRAL DISC PROTRUSION 120 0.0055
401 NEUROPATHY PERIPHERAL 522 0.0055
402 INCONTINENCE 58 0.0055
403 ANAEMIA 1046 0.0055
404 SPUTUM DISCOLOURED 52 0.0055
405 HEPATOTOXICITY 122 0.0055
406 MITRAL VALVE INCOMPETENCE 62 0.0055
407 SWOLLEN TONGUE 171 0.0055
408 SENSORY LOSS 44 0.0055
409 URINARY TRACT INFECTION 932 0.0055
410 GOUT 98 0.0055
411 PHARYNGEAL OEDEMA 84 0.0055
412 SEPSIS 609 0.0055
413 DIZZINESS 2720 0.0054
414 OSTEOARTHRITIS 231 0.0054
415 BURSITIS 66 0.0054
416 DEPRESSION 1235 0.0054
417 WEIGHT DECREASED 1515 0.0054
418 FURUNCLE 43 0.0054
419 IMPAIRED QUALITY OF LIFE 78 0.0054
420 LOW DENSITY LIPOPROTEIN INCREASED 42 0.0054
421 BLOOD CALCIUM DECREASED 61 0.0054
422 PYELONEPHRITIS 47 0.0054
423 PAIN OF SKIN 146 0.0054
424 GASTRIC ULCER 103 0.0054
425 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 260 0.0054
426 CONFUSIONAL STATE 872 0.0054
427 ORAL CANDIDIASIS 71 0.0054
428 TREMOR 894 0.0054
429 HAEMORRHOIDS 105 0.0054
430 ACNE 408 0.0054
431 INJECTION SITE PRURITUS 360 0.0054
432 POLYURIA 44 0.0054
433 ERYTHEMA MULTIFORME 50 0.0054
434 ORAL PAIN 120 0.0054
435 RASH PUSTULAR 39 0.0053
436 DIARRHOEA HAEMORRHAGIC 50 0.0053
437 HIP FRACTURE 172 0.0053
438 DRUG EFFECT DECREASED 288 0.0053
439 PRODUCT DOSE OMISSION 349 0.0053
440 NERVOUSNESS 279 0.0053
441 DYSPNOEA 3022 0.0053
442 DECREASED APPETITE 1239 0.0053
443 BEDRIDDEN 70 0.0053
444 ALANINE AMINOTRANSFERASE INCREASED 326 0.0053
445 ABNORMAL DREAMS 146 0.0053
446 RENAL PAIN 56 0.0053
447 INFLUENZA LIKE ILLNESS 434 0.0053
448 PHOTOSENSITIVITY REACTION 87 0.0053
449 EPISTAXIS 394 0.0053
450 DIARRHOEA 3396 0.0053
451 EAR INFECTION 140 0.0053
452 THROAT IRRITATION 236 0.0053
453 ORAL DISCOMFORT 73 0.0052
454 INJECTION SITE INDURATION 68 0.0052
455 FEELING COLD 146 0.0052
456 BLOOD POTASSIUM INCREASED 85 0.0052
457 WRONG TECHNIQUE IN DRUG USAGE PROCESS 190 0.0052
458 COUGH 1463 0.0052
459 PNEUMONITIS 142 0.0052
460 IMMUNOSUPPRESSION 46 0.0052
461 HEART RATE INCREASED 516 0.0052
462 ANGER 176 0.0052
463 CARDIOMEGALY 64 0.0052
464 BLOOD CREATININE INCREASED 339 0.0052
465 FLUID RETENTION 264 0.0052
466 VITREOUS FLOATERS 51 0.0052
467 INJECTION SITE ERYTHEMA 643 0.0052
468 DRUG DOSE OMISSION 856 0.0052
469 BURNING SENSATION 363 0.0052
470 SNEEZING 116 0.0052
471 SEPTIC SHOCK 225 0.0052
472 SUBDURAL HAEMATOMA 74 0.0052
473 FEAR 139 0.0052
474 STOMATITIS 313 0.0052
475 PERIPHERAL SWELLING 795 0.0052
476 CHOLELITHIASIS 169 0.0051
477 DENTAL CARIES 57 0.0051
478 BLOOD TRIGLYCERIDES INCREASED 91 0.0051
479 ATAXIA 61 0.0051
480 HYPERHIDROSIS 662 0.0051
481 EYE SWELLING 191 0.0051
482 MOOD ALTERED 140 0.0051
483 GASTROINTESTINAL INFECTION 46 0.0051
484 IMPAIRED HEALING 168 0.0051
485 FOOT FRACTURE 97 0.0051
486 ANOSMIA 74 0.0051
487 INJECTION SITE WARMTH 105 0.0051
488 RASH ERYTHEMATOUS 244 0.0051
489 MOTOR DYSFUNCTION 52 0.0051
490 MUSCULOSKELETAL STIFFNESS 446 0.0051
491 CYSTITIS 162 0.0051
492 OBESITY 81 0.0051
493 HERPES ZOSTER 292 0.0051
494 HYDRONEPHROSIS 38 0.0051
495 FISTULA 57 0.0051
496 RETCHING 108 0.0051
497 POST PROCEDURAL COMPLICATION 97 0.0050
498 ENCEPHALOPATHY 124 0.0050
499 PULMONARY ARTERIAL HYPERTENSION 73 0.0050
500 CONCUSSION 39 0.0050
501 BONE PAIN 295 0.0050
502 COORDINATION ABNORMAL 70 0.0050
503 SCIATICA 80 0.0050
504 PERICARDIAL EFFUSION 116 0.0050
505 MEMORY IMPAIRMENT 688 0.0050
506 ANXIETY 1425 0.0050
507 CHEST PAIN 927 0.0050
508 BACK DISORDER 81 0.0050
509 THIRST 89 0.0050
510 MOBILITY DECREASED 357 0.0050
511 HYPERKALAEMIA 174 0.0050
512 DELUSION 77 0.0050
513 PAIN IN EXTREMITY 1457 0.0049
514 WHITE BLOOD CELL COUNT DECREASED 536 0.0049
515 PYREXIA 1711 0.0049
516 LIMB DISCOMFORT 153 0.0049
517 PULMONARY OEDEMA 221 0.0049
518 HAIR TEXTURE ABNORMAL 66 0.0049
519 ARTHRITIS 388 0.0049
520 BLISTER 277 0.0049
521 ACUTE RESPIRATORY DISTRESS SYNDROME 87 0.0049
522 NAUSEA 3892 0.0049
523 SHOCK HAEMORRHAGIC 40 0.0049
524 BLOOD CHOLESTEROL INCREASED 229 0.0049
525 GASTROINTESTINAL PAIN 54 0.0049
526 PNEUMONIA BACTERIAL 45 0.0049
527 RENAL FAILURE 651 0.0049
528 PULMONARY FIBROSIS 94 0.0049
529 INJECTION SITE PAIN 1502 0.0049
530 HEPATIC STEATOSIS 91 0.0049
531 SKIN EXFOLIATION 412 0.0049
532 OXYGEN SATURATION DECREASED 274 0.0049
533 CHOLECYSTITIS 58 0.0049
534 OEDEMA 264 0.0049
535 ABDOMINAL PAIN LOWER 123 0.0049
536 SINUS TACHYCARDIA 69 0.0049
537 MACULAR DEGENERATION 58 0.0049
538 HALLUCINATION 365 0.0048
539 FUNGAL INFECTION 161 0.0048
540 NODULE 63 0.0048
541 NIGHTMARE 167 0.0048
542 HYPOKINESIA 70 0.0048
543 UPPER LIMB FRACTURE 96 0.0048
544 MUSCLE DISORDER 39 0.0048
545 SKIN DISCOLOURATION 221 0.0048
546 PHARYNGITIS STREPTOCOCCAL 52 0.0048
547 APATHY 70 0.0048
548 ABDOMINAL PAIN UPPER 987 0.0048
549 FOOD ALLERGY 37 0.0048
550 HAEMOLYSIS 37 0.0048
551 SKIN HAEMORRHAGE 71 0.0048
552 ANKLE FRACTURE 74 0.0048
553 DERMATITIS 100 0.0048
554 TACHYCARDIA 424 0.0048
555 MELAENA 105 0.0048
556 UNRESPONSIVE TO STIMULI 123 0.0048
557 RASH MACULO-PAPULAR 106 0.0048
558 APNOEA 37 0.0047
559 HEADACHE 2977 0.0047
560 NEPHROPATHY TOXIC 53 0.0047
561 ARTHRALGIA 1963 0.0047
562 JAUNDICE 127 0.0047
563 LYMPHADENOPATHY 167 0.0047
564 MIGRAINE 450 0.0047
565 VISION BLURRED 647 0.0047
566 JOINT SWELLING 568 0.0047
567 BODY TEMPERATURE INCREASED 96 0.0047
568 SOMNOLENCE 947 0.0047
569 PLATELET COUNT DECREASED 501 0.0047
570 PULMONARY MASS 70 0.0047
571 EYE INFECTION 53 0.0047
572 HAEMATOCHEZIA 259 0.0047
573 SKIN BURNING SENSATION 336 0.0047
574 SKIN LACERATION 51 0.0047
575 GENERALISED OEDEMA 58 0.0047
576 MULTI-ORGAN FAILURE 81 0.0047
577 DRY SKIN 625 0.0047
578 DRUG EFFECT INCOMPLETE 170 0.0047
579 DYSARTHRIA 176 0.0047
580 DEPRESSED MOOD 247 0.0047
581 HAEMATOMA 121 0.0047
582 APHASIA 141 0.0047
583 PLASMA CELL MYELOMA 182 0.0047
584 ERYTHEMA 958 0.0047
585 DIPLOPIA 121 0.0047
586 GLOSSODYNIA 104 0.0046
587 COLITIS 176 0.0046
588 INJECTION SITE EXTRAVASATION 57 0.0046
589 ESCHERICHIA INFECTION 38 0.0046
590 DELIRIUM 159 0.0046
591 NASOPHARYNGITIS 844 0.0046
592 ARTERIOSCLEROSIS 43 0.0046
593 INJECTION SITE URTICARIA 112 0.0046
594 SLEEP DISORDER 322 0.0046
595 HYPOTENSION 914 0.0046
596 THROAT TIGHTNESS 123 0.0045
597 HYPERTENSION 963 0.0045
598 PANCYTOPENIA 254 0.0045
599 HYPOTHERMIA 46 0.0045
600 PNEUMOTHORAX 72 0.0045
601 KIDNEY INFECTION 89 0.0045
602 HAEMATURIA 155 0.0045
603 VERTIGO 275 0.0045
604 RESTLESSNESS 165 0.0045
605 BLOOD PRESSURE INCREASED 689 0.0045
606 ILEUS 56 0.0045
607 SPEECH DISORDER 236 0.0045
608 MANIA 74 0.0045
609 APPLICATION SITE PAIN 99 0.0045
610 BLOOD TEST ABNORMAL 63 0.0045
611 ELECTROLYTE IMBALANCE 52 0.0045
612 SKIN IRRITATION 205 0.0045
613 OSTEOMYELITIS 81 0.0045
614 GINGIVAL BLEEDING 61 0.0045
615 CHOLECYSTECTOMY 51 0.0045
616 THINKING ABNORMAL 83 0.0044
617 LOSS OF LIBIDO 40 0.0044
618 ANAL INCONTINENCE 40 0.0044
619 FIBROMYALGIA 108 0.0044
620 ACUTE MYOCARDIAL INFARCTION 131 0.0044
621 AMNESIA 289 0.0044
622 COGNITIVE DISORDER 207 0.0044
623 WEIGHT INCREASED 988 0.0044
624 SKIN ULCER 114 0.0044
625 INCORRECT DRUG ADMINISTRATION DURATION 124 0.0044
626 INJECTION SITE MASS 163 0.0044
627 CARDIAC FAILURE CONGESTIVE 354 0.0044
628 NEPHROLITHIASIS 202 0.0044
629 CARDIOMYOPATHY 65 0.0044
630 RESPIRATORY RATE INCREASED 39 0.0044
631 PRODUCT ODOUR ABNORMAL 46 0.0044
632 SPINAL FRACTURE 88 0.0044
633 RESPIRATORY DISTRESS 121 0.0044
634 URINARY RETENTION 146 0.0044
635 SKIN LESION 120 0.0044
636 FACIAL PAIN 39 0.0044
637 ASTHMA 493 0.0044
638 PHARYNGITIS 54 0.0043
639 WHITE BLOOD CELL COUNT INCREASED 167 0.0043
640 JOINT DISLOCATION 46 0.0043
641 THYROID DISORDER 67 0.0043
642 NEUTROPHIL COUNT DECREASED 177 0.0043
643 MEDICATION ERROR 241 0.0043
644 HYPOTHYROIDISM 138 0.0043
645 MOUTH ULCERATION 91 0.0043
646 PETECHIAE 45 0.0043
647 COMA 205 0.0043
648 ABDOMINAL DISCOMFORT 722 0.0043
649 MYDRIASIS 55 0.0043
650 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 235 0.0043
651 CARDIAC MURMUR 37 0.0043
652 APPLICATION SITE ERYTHEMA 112 0.0043
653 LACRIMATION INCREASED 129 0.0043
654 TUBULOINTERSTITIAL NEPHRITIS 80 0.0043
655 DRUG ADMINISTERED AT INAPPROPRIATE SITE 45 0.0043
656 SCRATCH 45 0.0043
657 LOCALISED INFECTION 103 0.0043
658 MENSTRUATION IRREGULAR 114 0.0043
659 EYE PAIN 240 0.0042
660 RETINAL DETACHMENT 39 0.0042
661 HUNGER 59 0.0042
662 BRADYCARDIA 224 0.0042
663 WOUND 118 0.0042
664 GASTRITIS 111 0.0042
665 OESOPHAGITIS 46 0.0042
666 RASH 1834 0.0042
667 DRY EYE 210 0.0042
668 GLAUCOMA 81 0.0042
669 CONJUNCTIVITIS 78 0.0042
670 MULTIPLE SCLEROSIS RELAPSE 288 0.0042
671 RECALLED PRODUCT ADMINISTERED 40 0.0042
672 VOMITING 1969 0.0042
673 AGITATION 307 0.0042
674 EATING DISORDER 89 0.0042
675 VENTRICULAR TACHYCARDIA 69 0.0042
676 IRRITABILITY 250 0.0042
677 HAEMATEMESIS 105 0.0041
678 TASTE DISORDER 84 0.0041
679 ALOPECIA 811 0.0041
680 POST PROCEDURAL HAEMORRHAGE 48 0.0041
681 EYE HAEMORRHAGE 55 0.0041
682 PRURITUS 1582 0.0041
683 SYNCOPE 411 0.0041
684 INFLUENZA 458 0.0041
685 OVARIAN CYST 41 0.0041
686 QUALITY OF LIFE DECREASED 55 0.0041
687 SPLENOMEGALY 48 0.0041
688 FACE OEDEMA 69 0.0041
689 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 42 0.0041
690 ANGINA PECTORIS 117 0.0041
691 INJECTION SITE DISCOLOURATION 51 0.0041
692 RESPIRATORY DISORDER 122 0.0041
693 MULTIPLE SCLEROSIS 195 0.0041
694 INJECTION SITE RASH 125 0.0041
695 FOOT DEFORMITY 45 0.0041
696 EJECTION FRACTION DECREASED 63 0.0040
697 VENTRICULAR FIBRILLATION 45 0.0040
698 ERECTILE DYSFUNCTION 104 0.0040
699 TRANSAMINASES INCREASED 90 0.0040
700 BIPOLAR DISORDER 44 0.0040
701 GASTROENTERITIS 59 0.0040
702 HEPATIC ENZYME INCREASED 275 0.0040
703 DERMATITIS CONTACT 46 0.0040
704 SUICIDAL IDEATION 369 0.0040
705 DYSPHAGIA 382 0.0040
706 URTICARIA 670 0.0040
707 GENERALISED TONIC-CLONIC SEIZURE 66 0.0040
708 LUNG DISORDER 195 0.0040
709 BLOOD LACTATE DEHYDROGENASE INCREASED 63 0.0040
710 DERMATITIS ALLERGIC 50 0.0040
711 HYPERSENSITIVITY 736 0.0040
712 HYPOCALCAEMIA 75 0.0040
713 LYMPHOCYTE COUNT DECREASED 70 0.0040
714 LOWER LIMB FRACTURE 76 0.0040
715 DIALYSIS 56 0.0039
716 ASCITES 116 0.0039
717 MASS 55 0.0039
718 CENTRAL NERVOUS SYSTEM LESION 54 0.0039
719 INTESTINAL PERFORATION 44 0.0039
720 BLOOD PRESSURE FLUCTUATION 94 0.0039
721 BLOOD PRESSURE DECREASED 260 0.0039
722 INJURY 275 0.0039
723 NEUTROPHIL COUNT INCREASED 40 0.0039
724 SALIVARY HYPERSECRETION 39 0.0039
725 DECREASED ACTIVITY 42 0.0039
726 MOVEMENT DISORDER 125 0.0039
727 THROMBOSIS 313 0.0039
728 FEBRILE NEUTROPENIA 258 0.0039
729 HEPATIC FAILURE 117 0.0039
730 INFUSION SITE PAIN 50 0.0039
731 MADAROSIS 45 0.0039
732 BLOOD PRESSURE ABNORMAL 77 0.0039
733 IMMUNE SYSTEM DISORDER 51 0.0039
734 PSYCHOMOTOR HYPERACTIVITY 64 0.0039
735 CEREBRAL HAEMORRHAGE 138 0.0039
736 VISUAL ACUITY REDUCED 128 0.0038
737 INTERNAL HAEMORRHAGE 44 0.0038
738 PROSTATIC SPECIFIC ANTIGEN INCREASED 53 0.0038
739 GASTRIC DISORDER 132 0.0038
740 CHOKING 75 0.0038
741 FEMUR FRACTURE 119 0.0038
742 HEMIPARESIS 65 0.0038
743 THROMBOCYTOPENIA 429 0.0038
744 CONDITION AGGRAVATED 1166 0.0038
745 DRUG INTERACTION 607 0.0038
746 INJECTION SITE SWELLING 293 0.0038
747 INCREASED APPETITE 73 0.0038
748 DYSKINESIA 155 0.0038
749 MULTIPLE ORGAN DYSFUNCTION SYNDROME 108 0.0038
750 ABNORMAL BEHAVIOUR 151 0.0038
751 EYELID OEDEMA 44 0.0038
752 COELIAC DISEASE 37 0.0038
753 RENAL INJURY 112 0.0038
754 SKIN REACTION 53 0.0038
755 LOSS OF CONSCIOUSNESS 482 0.0038
756 LIMB INJURY 102 0.0038
757 RESPIRATORY DEPRESSION 46 0.0037
758 PSORIASIS 490 0.0037
759 LIVER INJURY 92 0.0037
760 GASTRIC HAEMORRHAGE 43 0.0037
761 MALIGNANT MELANOMA 50 0.0037
762 JOINT RANGE OF MOTION DECREASED 50 0.0037
763 ARRHYTHMIA 176 0.0037
764 NEUROLEPTIC MALIGNANT SYNDROME 44 0.0037
765 ULCER 59 0.0037
766 DRUG-INDUCED LIVER INJURY 116 0.0037
767 PHARMACEUTICAL PRODUCT COMPLAINT 96 0.0037
768 LOWER RESPIRATORY TRACT INFECTION 168 0.0037
769 INTESTINAL OBSTRUCTION 139 0.0037
770 SKIN FISSURES 72 0.0037
771 PAIN 2257 0.0037
772 SWELLING 342 0.0037
773 RENAL IMPAIRMENT 306 0.0036
774 ELECTROCARDIOGRAM QT PROLONGED 131 0.0036
775 IRRITABLE BOWEL SYNDROME 78 0.0036
776 ABSCESS 58 0.0036
777 DEAFNESS 95 0.0036
778 GAIT INABILITY 121 0.0036
779 HEART RATE DECREASED 127 0.0036
780 ARTHROPATHY 201 0.0036
781 HYPOGLYCAEMIA 175 0.0036
782 C-REACTIVE PROTEIN INCREASED 131 0.0036
783 AGGRESSION 180 0.0036
784 HYPERGLYCAEMIA 131 0.0036
785 SEDATION 94 0.0036
786 INTENTIONAL PRODUCT MISUSE 314 0.0036
787 SPINAL PAIN 42 0.0036
788 PSORIATIC ARTHROPATHY 145 0.0036
789 APPLICATION SITE PRURITUS 81 0.0036
790 WOUND INFECTION 39 0.0036
791 PANCREATITIS ACUTE 80 0.0036
792 MALAISE 1561 0.0036
793 DRUG ADMINISTRATION ERROR 109 0.0035
794 WITHDRAWAL SYNDROME 149 0.0035
795 BLINDNESS UNILATERAL 50 0.0035
796 SEIZURE 409 0.0035
797 PANCREATITIS 187 0.0035
798 PRODUCT QUALITY ISSUE 480 0.0035
799 BLOOD GLUCOSE DECREASED 169 0.0035
800 BONE DENSITY DECREASED 110 0.0035
801 DEVICE DISLOCATION 152 0.0035
802 APPLICATION SITE RASH 48 0.0035
803 DEPRESSED LEVEL OF CONSCIOUSNESS 138 0.0035
804 SKIN CANCER 75 0.0035
805 SHOCK 80 0.0035
806 INFECTION 502 0.0035
807 HERNIA 67 0.0035
808 PRESCRIBED UNDERDOSE 69 0.0035
809 HAIR COLOUR CHANGES 43 0.0035
810 HYPERTHYROIDISM 50 0.0035
811 DISEASE PROGRESSION 408 0.0034
812 COMPLICATION ASSOCIATED WITH DEVICE 50 0.0034
813 INFLAMMATION 177 0.0034
814 GLOMERULAR FILTRATION RATE DECREASED 42 0.0034
815 GASTROINTESTINAL DISORDER 306 0.0034
816 INJECTION SITE REACTION 235 0.0034
817 GENERAL PHYSICAL HEALTH DETERIORATION 395 0.0034
818 EYE DISORDER 112 0.0034
819 HALLUCINATION, AUDITORY 54 0.0034
820 CARDIAC ARREST 279 0.0034
821 BLOOD GLUCOSE FLUCTUATION 37 0.0034
822 STATUS EPILEPTICUS 38 0.0034
823 HIP ARTHROPLASTY 51 0.0033
824 DRUG LEVEL INCREASED 55 0.0033
825 ADVERSE DRUG REACTION 297 0.0033
826 LACTIC ACIDOSIS 107 0.0033
827 IMPAIRED GASTRIC EMPTYING 45 0.0033
828 CONVULSION 188 0.0033
829 MENTAL DISORDER 143 0.0033
830 NO THERAPEUTIC RESPONSE 40 0.0033
831 HAEMORRHAGE INTRACRANIAL 49 0.0033
832 PALLOR 89 0.0033
833 VISUAL IMPAIRMENT 404 0.0033
834 DEMENTIA 91 0.0033
835 ROAD TRAFFIC ACCIDENT 136 0.0032
836 PRODUCT TASTE ABNORMAL 44 0.0032
837 COLITIS ULCERATIVE 145 0.0032
838 OCULAR HYPERAEMIA 153 0.0032
839 IMMUNODEFICIENCY 48 0.0032
840 TOOTH EXTRACTION 40 0.0032
841 EMOTIONAL DISORDER 99 0.0032
842 TYPE 2 DIABETES MELLITUS 108 0.0032
843 POLYNEUROPATHY 38 0.0032
844 LIVER FUNCTION TEST INCREASED 68 0.0032
845 ANAPHYLACTIC REACTION 174 0.0031
846 CARDIOGENIC SHOCK 45 0.0031
847 RENAL DISORDER 146 0.0031
848 ADRENAL INSUFFICIENCY 38 0.0031
849 BLOOD PRESSURE SYSTOLIC INCREASED 61 0.0031
850 MUSCLE RIGIDITY 37 0.0031
851 HEPATIC CIRRHOSIS 58 0.0031
852 PSYCHOTIC DISORDER 91 0.0031
853 SEROTONIN SYNDROME 59 0.0031
854 CIRCULATORY COLLAPSE 52 0.0031
855 CARDIAC DISORDER 285 0.0030
856 CARDIAC FAILURE 244 0.0030
857 NEUTROPENIA 410 0.0030
858 DRUG INEFFECTIVE 3972 0.0030
859 DRUG TOXICITY 41 0.0030
860 HEPATITIS 77 0.0030
861 FEEDING DISORDER 61 0.0030
862 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 51 0.0030
863 DISCOMFORT 183 0.0030
864 KNEE ARTHROPLASTY 63 0.0030
865 DEVICE MALFUNCTION 210 0.0030
866 GAMMA-GLUTAMYLTRANSFERASE INCREASED 66 0.0030
867 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51 0.0030
868 ECONOMIC PROBLEM 45 0.0030
869 INCORRECT PRODUCT STORAGE 39 0.0030
870 ANGIOEDEMA 131 0.0030
871 RHEUMATOID ARTHRITIS 333 0.0029
872 DIABETES MELLITUS 223 0.0029
873 EYE PRURITUS 98 0.0029
874 CHOLESTASIS 56 0.0029
875 PLATELET COUNT INCREASED 38 0.0029
876 LYMPHOMA 45 0.0029
877 MUCOSAL INFLAMMATION 75 0.0029
878 UNDERDOSE 209 0.0029
879 INJECTION SITE HAEMATOMA 41 0.0028
880 BLOOD GLUCOSE INCREASED 531 0.0028
881 BLOOD CREATINE PHOSPHOKINASE INCREASED 81 0.0028
882 DRUG DISPENSING ERROR 43 0.0028
883 CEREBRAL INFARCTION 68 0.0028
884 TOXICITY TO VARIOUS AGENTS 467 0.0028
885 DEVICE ISSUE 248 0.0028
886 HAEMORRHAGE 289 0.0028
887 ACUTE MYELOID LEUKAEMIA 43 0.0028
888 LEUKOPENIA 137 0.0027
889 HYPOACUSIS 117 0.0027
890 PROCEDURAL PAIN 75 0.0027
891 CEREBROVASCULAR ACCIDENT 454 0.0027
892 ANAPHYLACTIC SHOCK 69 0.0027
893 DEVICE EXPULSION 173 0.0027
894 EYE IRRITATION 153 0.0027
895 CARDIO-RESPIRATORY ARREST 111 0.0027
896 DRUG PRESCRIBING ERROR 51 0.0027
897 PREGNANCY 53 0.0026
898 RHABDOMYOLYSIS 110 0.0026
899 INCORRECT ROUTE OF DRUG ADMINISTRATION 94 0.0026
900 ANHEDONIA 69 0.0026
901 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 61 0.0026
902 MUSCULOSKELETAL DISORDER 49 0.0026
903 LIVER DISORDER 114 0.0026
904 INSURANCE ISSUE 39 0.0025
905 INCORRECT DOSE ADMINISTERED 572 0.0025
906 INTENTIONAL PRODUCT USE ISSUE 219 0.0025
907 PRODUCT PHYSICAL ISSUE 50 0.0025
908 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 175 0.0025
909 AMENORRHOEA 43 0.0024
910 METASTASES TO BONE 40 0.0024
911 MULTIPLE FRACTURES 40 0.0024
912 MYOCARDIAL INFARCTION 424 0.0024
913 DRUG INTOLERANCE 233 0.0024
914 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
915 PERITONITIS 49 0.0024
916 THERAPY NON-RESPONDER 106 0.0024
917 PRODUCT USE ISSUE 442 0.0023
918 OVERDOSE 506 0.0023
919 INTERSTITIAL LUNG DISEASE 113 0.0023
920 HOSPITALISATION 358 0.0023
921 INTENTIONAL OVERDOSE 148 0.0023
922 NERVOUS SYSTEM DISORDER 72 0.0023
923 OFF LABEL USE 1997 0.0023
924 METASTASES TO LIVER 40 0.0023
925 ACCIDENTAL OVERDOSE 83 0.0023
926 EXPIRED PRODUCT ADMINISTERED 74 0.0022
927 PRESCRIBED OVERDOSE 43 0.0022
928 EXTRA DOSE ADMINISTERED 90 0.0022
929 PROTEINURIA 42 0.0022
930 DIABETIC KETOACIDOSIS 53 0.0022
931 TREATMENT NONCOMPLIANCE 120 0.0022
932 ECZEMA 114 0.0022
933 MALIGNANT NEOPLASM PROGRESSION 223 0.0022
934 SURGERY 126 0.0021
935 DIABETES MELLITUS INADEQUATE CONTROL 38 0.0021
936 PRODUCT PRESCRIBING ERROR 51 0.0021
937 THERAPY INTERRUPTED 153 0.0021
938 CARDIOVASCULAR DISORDER 53 0.0021
939 BLOOD GLUCOSE ABNORMAL 38 0.0021
940 INFUSION RELATED REACTION 136 0.0020
941 INTENTIONAL DRUG MISUSE 42 0.0020
942 ILL-DEFINED DISORDER 122 0.0020
943 ABORTION SPONTANEOUS 80 0.0020
944 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
945 EXPOSURE DURING PREGNANCY 119 0.0019
946 RESPIRATORY ARREST 52 0.0019
947 INTENTIONAL DOSE OMISSION 53 0.0019
948 SUICIDE ATTEMPT 111 0.0018
949 INJURY ASSOCIATED WITH DEVICE 37 0.0018
950 OSTEONECROSIS OF JAW 44 0.0018
951 LUNG NEOPLASM MALIGNANT 73 0.0018
952 BLINDNESS 72 0.0018
953 DISEASE RECURRENCE 84 0.0018
954 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 59 0.0017
956 DRUG WITHDRAWAL SYNDROME 153 0.0017
957 TARDIVE DYSKINESIA 48 0.0017
958 THERAPEUTIC RESPONSE DECREASED 102 0.0017
959 DRUG EXPOSURE DURING PREGNANCY 57 0.0017
960 OSTEONECROSIS 55 0.0017
961 EMOTIONAL DISTRESS 201 0.0017
962 NEEDLE ISSUE 48 0.0016
963 ADVERSE EVENT 150 0.0016
964 PRODUCT USE IN UNAPPROVED INDICATION 393 0.0016
965 DEATH 1360 0.0016
966 HEPATIC FUNCTION ABNORMAL 58 0.0016
967 SYSTEMIC LUPUS ERYTHEMATOSUS 55 0.0015
968 NEOPLASM PROGRESSION 53 0.0015
969 EPILEPSY 46 0.0015
970 COVID-19 262 0.0015
971 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 266 0.0015
973 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
974 PRODUCT ADHESION ISSUE 50 0.0014
975 BREAST CANCER 122 0.0013
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 258 0.0013
977 THERAPEUTIC RESPONSE SHORTENED 42 0.0013
978 NEOPLASM MALIGNANT 81 0.0012
979 DEVICE LEAKAGE 50 0.0012
980 THERAPEUTIC PRODUCT EFFECT DECREASED 51 0.0011
981 TREATMENT FAILURE 92 0.0011
982 ILLNESS 109 0.0011
983 PROSTATE CANCER 80 0.0010
984 DEVICE BREAKAGE 38 0.0009
985 MATERNAL EXPOSURE DURING PREGNANCY 82 0.0009
986 PRODUCT DOSE OMISSION ISSUE 264 0.0009
987 FOETAL EXPOSURE DURING PREGNANCY 70 0.0009
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 38 0.0008
989 COMPLETED SUICIDE 51 0.0006
990 ACCIDENTAL EXPOSURE TO PRODUCT 51 0.0005
991 NO ADVERSE EVENT 88 0.0005
992 DRUG DEPENDENCE 70 0.0004